ADTX:NSD-Aditxt Inc. (USD)

COMMON STOCK | Biotechnology |

Last Closing

USD 0.1633

Change

0.00 (0.00)%

Market Cap

USD 0.88M

Volume

0.01B

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Aditxt, Inc., a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. It also develops ADI-100 for skin grafting, psoriasis, type 1 diabetes, and multiple sclerosis. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia. Address: 737 North Fifth Street, Richmond, VA, United States, 23219

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-28 )

Largest Industry Peers for Biotechnology

Symbol Name Price(Change) Market Cap
VRTX Vertex Pharmaceuticals Inc

N/A

USD 119.56B
REGN Regeneron Pharmaceuticals Inc

N/A

USD 114.65B
ALNY Alnylam Pharmaceuticals Inc

N/A

USD 35.29B
ARGX argenx NV ADR

N/A

USD 32.06B
MRNA Moderna Inc

N/A

USD 25.25B
BGNE BeiGene Ltd

N/A

USD 24.38B
RPRX Royalty Pharma Plc

N/A

USD 16.72B
UTHR United Therapeutics Corporatio..

N/A

USD 15.71B
SMMT Summit Therapeutics PLC

N/A

USD 15.35B
PCVX Vaxcyte Inc

N/A

USD 14.00B

ETFs Containing ADTX

EXH8:XETRA iShares (DE) I - iShares .. 30.40 % 0.00 %

N/A

USD 0.01B
CS1:LSE Amundi IBEX 35 UCITS ETF .. 15.88 % 0.00 %

N/A

USD 0.09B
CS1:PA Amundi IBEX 35 UCITS ETF .. 15.64 % 0.00 %

N/A

USD 0.09B
AMES:XETRA Amundi IBEX 35 UCITS ETF .. 15.64 % 0.00 %

N/A

USD 0.07B
XESD:F Xtrackers - Spain UCITS E.. 10.74 % 0.00 %

N/A

USD 0.23B
XESP:F Xtrackers Spain UCITS ETF.. 10.74 % 0.00 %

N/A

USD 0.23B
XESD:XETRA Xtrackers Spain UCITS ETF.. 10.74 % 0.00 %

N/A

USD 0.23B
XESP:XETRA Xtrackers Spain UCITS 1C 10.74 % 0.00 %

N/A

USD 0.23B
LOWD:XETRA BNP PARIBAS EASY - Low Ca.. 9.49 % 0.00 %

N/A

USD 0.05B
LCWLD:PA BNP PARIBAS EASY - Low Ca.. 9.49 % 0.00 %

N/A

N/A
LOWD:F BNP PARIBAS EASY - Low Ca.. 9.49 % 0.00 %

N/A

N/A
ELFB:XETRA Deka Oekom Euro Nachhalti.. 7.38 % 0.00 %

N/A

USD 0.23B
EGRG:LSE WisdomTree Eurozone Quali.. 6.38 % 0.00 %

N/A

USD 0.05B
ESIC:LSE iShares MSCI Europe Consu.. 5.92 % 0.00 %

N/A

USD 0.24B
WTIM:F WisdomTree Eurozone Quali.. 5.88 % 0.00 %

N/A

USD 0.07B
WTIM:XETRA WisdomTree Eurozone Quali.. 5.88 % 0.00 %

N/A

USD 0.07B
XZEC:XETRA Xtrackers MSCI Europe Con.. 5.85 % 0.00 %

N/A

USD 7.18M
EGRA:SW WisdomTree Eurozone Quali.. 5.51 % 0.00 %

N/A

N/A
ESIC:XETRA iShares MSCI Europe Consu.. 5.37 % 0.00 %

N/A

USD 0.28B
IQD-B:CA CI WisdomTree Internation.. 5.17 % 0.00 %

N/A

CAD 0.40B
STR:PA SPDR® MSCI Europe Consum.. 5.15 % 0.00 %

N/A

USD 0.10B
SPYR:XETRA SPDR® MSCI Europe Consum.. 5.15 % 0.00 %

N/A

USD 0.14B
STRX:SW SPDR® MSCI Europe Consum.. 5.15 % 0.00 %

N/A

USD 0.10B
EGRW:SW 5.13 % 0.00 %

N/A

N/A
CDCE:LSE SPDR® MSCI Europe Consum.. 4.85 % 0.00 %

N/A

N/A
EDGF:CA Brompton European Dividen.. 4.51 % 0.00 %

N/A

CAD 0.02B
PJIO PGIM ETF Trust 4.46 % 0.00 %

N/A

USD 0.01B
UD04:LSE UBS(Lux)Fund Solutions .. 3.67 % 0.00 %

N/A

USD 0.17B
BKIS 3.65 % 0.00 %

N/A

N/A
FCSI:CA Franklin ClearBridge Sust.. 3.64 % 0.00 %

N/A

CAD 4.50M
ASRV:XETRA BNP Paribas Easy ESG Euro.. 3.33 % 0.00 %

N/A

N/A
UIM2:F UBS (Lux) Fund Solutions .. 3.29 % 0.00 %

N/A

USD 0.16B
UIM2:XETRA UBS(Lux)Fund Solutions .. 3.29 % 0.00 %

N/A

USD 0.11B
EQLTD:SW UBS(Lux)Fund Solutions .. 3.12 % 0.00 %

N/A

N/A
EQLTS:SW UBS(Lux)Fund Solutions .. 3.12 % 0.00 %

N/A

N/A
IBC0:XETRA iShares Edge MSCI Europe .. 2.64 % 0.00 %

N/A

USD 0.21B
XZEZ:LSE Xtrackers MSCI EMU ESG UC.. 2.61 % 0.00 %

N/A

USD 0.04B
XZEZ:XETRA Xtrackers MSCI EMU ESG UC.. 2.53 % 0.00 %

N/A

USD 0.06B
XZEZ:SW Xtrackers MSCI EMU ESG UC.. 2.53 % 0.00 %

N/A

USD 0.04B
IFSE:SW iShares Edge MSCI Europe .. 2.49 % 0.00 %

N/A

USD 0.26B
TDI Touchstone Dynamic Intern.. 2.46 % 0.00 %

N/A

N/A
FICS First Trust International.. 2.23 % 0.00 %

N/A

USD 0.16B
FLEQ:SW 2.13 % 0.00 %

N/A

N/A
TGGR:CA TD Active Global Equity G.. 2.12 % 0.00 %

N/A

CAD 0.04B
RID:CA RBC Quant EAFE Dividend L.. 1.94 % 0.54 %

N/A

CAD 0.11B
RID-U:CA RBC Quant EAFE Dividend L.. 1.94 % 0.00 %

N/A

N/A
MVEE:XETRA iShares Edge MSCI Europe .. 1.64 % 0.00 %

N/A

USD 0.07B
MVEE:SW iShares Edge MSCI Europe .. 1.64 % 0.00 %

N/A

USD 0.07B
EUN0:XETRA iShares Edge MSCI Europe .. 1.61 % 0.00 %

N/A

USD 0.79B
MVEU:SW iShares Edge MSCI Europe .. 1.61 % 0.00 %

N/A

USD 0.76B
PAES:LSE Invesco MSCI Europe ESG C.. 1.36 % 0.00 %

N/A

USD 0.05B
PAEU:SW Invesco MSCI Europe ESG C.. 1.29 % 0.00 %

N/A

USD 0.05B
DOL WisdomTree International .. 0.00 % 0.48 %

N/A

N/A
DWM WisdomTree International .. 0.00 % 0.48 %

N/A

N/A
EUDG WisdomTree Europe Quality.. 0.00 % 0.58 %

N/A

N/A
EWP iShares MSCI Spain ETF 0.00 % 0.47 %

N/A

N/A
IHDG WisdomTree International .. 0.00 % 0.58 %

N/A

N/A
GENY 0.00 % 0.45 %

N/A

N/A
FINT:CA First Trust International.. 0.00 % 0.75 %

N/A

CAD 6.57M
CDIS:LSE SPDR® MSCI Europe Consum.. 0.00 % 0.00 %

N/A

N/A
DQI:CA 0.00 % 0.71 %

N/A

N/A
IQD:CA CI WisdomTree Internation.. 0.00 % 0.65 %

N/A

N/A
MIVG:CA Mackenzie Ivy Global Equi.. 0.00 % 0.89 %

N/A

CAD 0.02B
EGRA:LSE WisdomTree Eurozone Quali.. 0.00 % 0.00 %

N/A

N/A
EGRP:LSE WisdomTree Eurozone Quali.. 0.00 % 0.00 %

N/A

N/A
EGRW:LSE WisdomTree Eurozone Quali.. 0.00 % 0.00 %

N/A

N/A
IMV:LSE iShares Edge MSCI Europe .. 0.00 % 0.00 %

N/A

N/A
MVED:LSE iShares Edge MSCI Europe .. 0.00 % 0.00 %

N/A

N/A
MVEU:LSE iShares Edge MSCI Europe .. 0.00 % 0.00 %

N/A

N/A
EXH8:F iShares (DE) I - iShares .. 0.00 % 0.00 %

N/A

N/A
SPYR:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

N/A

N/A
FVUE:XETRA 0.00 % 0.00 %

N/A

N/A
FLEQ:LSE 0.00 % 0.00 %

N/A

N/A
FREQ:LSE 0.00 % 0.00 %

N/A

N/A
IMVU:LSE iShares Edge MSCI Europe .. 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Biotechnology) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4,826.09% 89% A- 96% N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 4,826.09% 89% A- 96% N/A
Trailing 12 Months  
Capital Gain 2,514.89% 86% B+ 95% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 2,514.89% 86% B+ 95% A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 43.43% N/A N/A 89% A-
Dividend Return 43.43% N/A N/A 88% B+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 1,294.64% N/A N/A 3% F
Risk Adjusted Return 3.35% N/A N/A 41% F
Market Capitalization 0.88M 1% F 1% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative earnings

The company had negative total earnings in the most recent four quarters.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector